Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Basiliximab × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 5 Other hematologic neoplasm 4 Myeloid 3 Plasma cell 2 Classical hematology 2 CNS 2 Tumor-Agnostic 1 Sarcoma 1

Conditions

Gliosarcoma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 193 Radiotherapy 192 Doxorubicin 187 Temozolomide 164 Ifosfamide 106 Filgrastim 98 Imatinib Mesylate 92 Etoposide 89 Vincristine 83 Gemcitabine 76 Bevacizumab 73 Irinotecan 72 Magnetic Resonance Spectroscopy 69 Radiation 63 pembrolizumab 62 Carboplatin 56 Methotrexate 55 pazopanib 54 fludarabine phosphate 51 Cisplatin 51 Trabectedin 49 Specimen Handling 49 Nivolumab 48 Surgical Procedures, Operative 47 Peripheral Blood Stem Cell Transplantation 46 Biopsy 46 Docetaxel 44 Busulfan 43 Melphalan 42 Paclitaxel 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00626483 2021-03-09

REGULATe

Duke University

Phase 1 Completed

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡